Peptidic aldehydes based on α- and β-amino acids: Synthesis, inhibition of m-Calpain, and anti-cataract properties

Australian Journal of Chemistry

Volumn 57, Issue 9, 2004, Pages 877-884

  Payne, Richard J ^a   Brown, Karina M ^a   Coxon, James M ^a   Morton, James D ^b   Lee, Hannah Yun Young ^b   Abell, Andrew D ^a  

^a UNIVERSITY OF CANTERBURY   (New Zealand)

^b LINCOLN UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; AMINO ACIDS; DRUG PRODUCTS; ENZYME INHIBITION; MOLECULAR STRUCTURE; SOLUBILITY; SYNTHESIS (CHEMICAL); VISION;

BIOSTABILITY; CATARACT; PEPTIDE-BASED DRUGS; PEPTIDIC ALDEHYDES;

POLYPEPTIDES;

EID: 6344219635     PISSN: 00049425     EISSN: None     Source Type: Journal    
DOI: 10.1071/CH04080     Document Type: Conference Paper

References (37)

1. G.-D. Lin, D. Chattopadhyay, M. Maki, K. K. W. Wang, M. Carson, L. Jin, P.-W. Yuen, E. Takano, et al., Nat. Struct. Biol. 1997, 4, 539.
2. D. E. Croall, K. S. McGrody, Biochemistry 1994, 33, 13 223.
3. D. Reverter, S. Strobl, C. Fernandez-Catalan, H. Sorimachi, K. Suzuki, W. Bode, Biol. Chem. 2001, 382, 753.
4. T. Moldoveanu, C. M. Hosfield, D. Lim, J. S. Elce, Z. Jia, P. L. Davies, Cell 2002, 108, 649. doi:10.1016/S0092-8674(02)00659-1
5. R. Betts, S. Weinsheimer, G. E. Blouse, J. Anagli, J. Biol. Chem. 2003, 278, 7800. doi:10.1074/JBC.M208350200
6. P. W. Vanderklish, B. A. Bahr, Int. J. Exp. Pathol. 2000, 81, 323.
7. S. Chatterjee, Z.-Q. Gu, D. Dunn, M. Tao, K. Josef, R. Tripathy, R. Bihovsky, S. E. Senadhi, et al., J. Med. Chem. 1998, 41, 2663. doi:10.1021/JM980035Y
8. P.-W. Yuen, K. K. W. Wang, Drugs Future 1998, 23, 741.
9. (a) C. Fukiage, M. Azuma, Y. Nakamura, Y. Tamada, M. Nakamura, T. R. Shearer, Biochim. Biophys. Acta 1997, 1361, 304. doi:10.1016/S0925-4439(97) 00043-4
10. (b) Y. Tamada, C. Fukiage, K. Mizutani, M. Yamaguchi, Y. Nakamura, M. Azuma, T. R. Shearer, Curr. Eye Res. 2001, 22, 280. doi:10.1076/CEYR.22.4.280. 5505
11. (c)Y. M. Nakamura, O. Sakai, J. Inoue, Bioorg. Med. Chem. Lett. 2003, 11, 1371. doi:10.1016/S0968-0896(02)00612-0
12. P. Mathur, S. K. Gupta, A. R. Wegener, W. Breipohl, M. H. Ahrend, Y. D. Sharma, Y. K. Gupta, R. B. Vajpayee, Curr. Eye Res. 2000, 21, 926. doi:10.1076/CEYR.21.6.926.6990
13. M. Nakamura, M. Yamaguchi, O. Sakai, J. Inoue, Bioorg. Med. Chem. 2003, 11, 1371. doi:10.1016/S0968-0896(02)00612-0
14. B. Thylefors, A. D. Negrel, R. Pararajasegaram, K. Y. Dadzie, Bull. World Health Organ. 1995, 73, 115.
15. J. Inoue, M. Nakamura, Y.-S. Cui, Y. Sakai, O. Sakai, J. R. Hill, K. K. W. Wang, P.-W. Yuen, J. Med. Chem. 2002, 46, 868. doi:10.1021/JM0201924
16. M. Nakamura, H. Miyashita, M. Yamaguchi, Y. Shirasaki, Y. Nakamura, J. Inoue, Bioorg. Med. Chem. 2003, 11, 5449. doi: 10.1016/J.BMC.2003.09.031
17. J. S. C. Arthur, S. Gauthier, J. S. Elce, FEBS Lett. 1995, 368, 397. doi: 10.1016/0014-5793(95)00691-2
18. I. O. Donkor, Curr. Med. Chem. 2000, 7, 1171.
19. M. Iqbal, P. A. Messina, B. Freed, M. Das, S. Chatterjee, T. Rabindran, M. Tao, K. A. Josef, et al., Bioorg. Med. Chem. Lett. 1997, 7, 539. doi:10.1016/S0960-894X(97)00063-2
20. R. Tripathy, Z.-Q. Gu, D. Dunn, S. E. Senadhi, M. A. Ator, S. Chatterjee, Bioorg. Med. Chem. Lett. 1998, 8, 2647. doi: 10.1016/S0960-894X(98)00470-3
21. I. O. Donkor, J. Han, X. Zheng, J. Med. Chem. 2004, 47, 72. doi:10.1021/JM0301336
22. S. Chatterjee, M. Iqbal, S. Mallya, S. E. Senadhi, T. M. O'Kane, B. A. McKenna, D. Bozyczko-Coyne, J. C. Kauer, et al., Bioorg. Med. Chem. 1998, 6, 509. doi:10.1016/S0968-0896(98)00009-1
23. S. Chatterjee, D. Dunn, M. Tao, G. Wells, Z.-Q. Gu, R. Bihovsky, M. A. Ator, R. Siman, J. P. Mallamo, Bioorg. Med. Chem. Lett. 1999, 9, 2371. doi:10.1016/S0960-894X(99)00392-3
24. W. Lubisch, A. Moller, Bioorg. Med. Chem. Lett. 2002, 12, 1335. doi:10.1016/S0960-894X(02)00176-2
25. A. A. Hernandez, W. R. Roush, Curr. Opin. Chem. Biol. 2002, 6, 459. doi:10.1016/S1367-5931(02)00345-9
26. I. O. Donkor, R. Korukonda, T. L. Huang, L. LeCour, Bioorg. Med. Chem. Lett. 2003, 13, 783. doi:10.1016/S0960-894X(03)00021-0
27. K. K. W. Wang, R. Nath, A. Posner, K. J. Raser, B.-K. Michalle, I. Hajimohammadreza, A. W. J. Probert, F. W. Marcoux, et al., Proc. Natl. Acad. Sci. USA 1996, 93, 6687. doi: 10.1073/PNAS.93.13.6687
28. L. Huang, A. Lee, J. A. Ellman, J. Med. Chem. 2002, 45, 676. doi:10.1021/JM010333M
29. (a) J. Podlech, D. Seebach, Liebigs Ann. 1995, 1217.
30. (b) D. Seebach, H. Esterman, Tetrahedron Lett. 1987, 28, 3103 doi:10.1016/S0040-4039(00)96296-8
31. Note the use of Schechter-Berger nomenclature. The residues on the N-terminal side of the peptide bond that is cleaved are denoted (in order) P1-Pn, and those on the C-terminus are denoted P1′-Pn′. In turn, the corresponding subsites on the enzyme are denoted Sn-Sn′. I. Schechter, A. Berger, Biochem. Biophys. Res. Commun. 1967, 27, 157.
32. V. F. Thompson, S. Saldana, J. Cong, D. E. Goll, Anal. Biochem. 2000, 279, 170. doi:10.1006/ABIO.1999.4475
33. J. Sanderson, J. M. Marciantonio, G. A. Duncan, Invest. Opth. Vis. Sci. 2000, 41, 2255.
34. J. C. A. Hunt, C. Lloyd, C. J. Moody, A. M. Z. Slawin, A. K. Takle, J. Chem. Soc., Perkin Trans. 1 1999, 3443. doi:10.1039/A907186E
35. For data on the corresponding HCl salt see: R. Caputo, E. Cassano, L. Longobardo, G. Palumbo, Tetrahedron 1995, 51, 12 337. doi:10.1016/0040-4020(95) 00778-7
36. E. M. Gordon, J. D. Godfrey, N. G. Delaney, M. M. Asaad, D. Von Langen, D. W. Cushman, J. Med. Chem. 1988, 31, 2199.
37. D. Seebach, M. Overhand, F. N. M. Kuehnle, B. Martinoni, L. Oberer, Helv. Chim. Acta 1996, 79, 913.